دورية أكاديمية

Human T-lymphotropic virus type 1 infection and disease in Spain

التفاصيل البيبلوغرافية
العنوان: Human T-lymphotropic virus type 1 infection and disease in Spain
المؤلفون: Mendoza, Carmen de, Caballero, Estrella, Aguilera, Antonio, Requena, Silvia, Ortiz de Lejarazu, Raúl, Pirón, María, González, Rocío, Jiménez, Ana, Roc, Lourdes, Treviño, Ana, Benito, Rafael, Fernández-Alonso, Miriam, Aguinaga, Aitziber, Rodríguez, Carmen, García-Costa, Juan, Blanco, Lidia, Ramos, José M., Calderón, Enrique J., Eirós, José M., Sauleda, Silvia, Barreiro, Pablo, Soriano, Vicente
المساهمون: Instituto de Salud Carlos III, European Commission
بيانات النشر: Lippincott Williams & Wilkins
سنة النشر: 2017
المجموعة: Digital.CSIC (Consejo Superior de Investigaciones Científicas / Spanish National Research Council)
مصطلحات موضوعية: Adult T-cell leukemia, Blood banks, Epidemiology, Human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis, Human T-lymphotropic virus type, Transplantation
الوصف: Human T-lymphotropic virus type 1 (HTLV-1) infection is a neglected disease despite roughly 15 million people are chronically infected worldwide. Lifelong less than 10% of carriers develop life-threatening diseases, mostly a subacute myelopathy known as tropical spastic paraparesis (TSP) and a lymphoproliferative disorder named adult T-cell leukemia (ATL). HTLV-1 is efficiently transmitted perinatally (breastfeeding), sexually (more from men to women) and parenterally (transfusions, injection drug user (IDU), and transplants). To date there is neither prophylactic vaccine nor effective antiviral therapy. A total of 327 cases of HTLV-1 infection had been reported at the HTLV-1 Spanish registry until December 2016, of whom 34 had been diagnosed with TSP and 25 with ATL. Overall 62% were Latin American immigrants and 13% were persons of African origin. The incidence of HTLV-1 in Spain has remained stable for nearly a decade with 20–25 new cases yearly. Of the 21 newly diagnosed HTLV-1 cases during year 2016, one was a native Spaniard pregnant woman, and four presented with symptomatic disease, including three with ATL and one with TSP. Underdiagnosis of HTLV-1 in Spain must be high (iceberg model), which may account for the disproportionate high rate of symptomatic cases (almost 20%) and the late recognition of preventable HTLV-1 transmissions in special populations, such as newborns and transplant recipients. Our current estimate is of 10 000 persons living with HTLV-1 infection in Spain. Given the large flux of immigrants and visitors from HTLV-1 endemic regions to Spain, the expansion of HTLV-1 screening policies is warranted. At this time, it seems worth recommending HTLV testing to all donor/recipient organ transplants and pregnant women regardless place of birth. Although current leukoreduction procedures largely prevent HTLV-1 transmission by blood transfusions, HTLV testing of all first-time donors should be cost-effective contributing to unveil asymptomatic unaware HTLV-1 carriers. ; The work was funded in ...
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 0269-9370
1473-5571
العلاقة: https://doi.org/10.1097/QAD.0000000000001527Test; Sí; AIDS 31(12): 1653-1663 (2017); http://hdl.handle.net/10261/182228Test; http://dx.doi.org/10.13039/501100000780Test; http://dx.doi.org/10.13039/501100004587Test
DOI: 10.1097/QAD.0000000000001527
DOI: 10.13039/501100000780
DOI: 10.13039/501100004587
الإتاحة: https://doi.org/10.1097/QAD.0000000000001527Test
https://doi.org/10.13039/501100000780Test
https://doi.org/10.13039/501100004587Test
http://hdl.handle.net/10261/182228Test
حقوق: none
رقم الانضمام: edsbas.BD34D2EF
قاعدة البيانات: BASE
الوصف
تدمد:02699370
14735571
DOI:10.1097/QAD.0000000000001527